Pieris Pharmaceuticals
PIRS
$11.08
Share price
-1.42%
Change (1 day)
1,338.96%
Change (1 year)
Categories
Market capitalization of Pieris Pharmaceuticals (PIRS)
Market cap: $13.7 Million
As of May 2024 Pieris Pharmaceuticals has a market cap of $13.7 Million. This makes Pieris Pharmaceuticals the world's 8076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Pieris Pharmaceuticals from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $13.7 M | -23.84% |
| 2023 | $17.99 M | -76.75% |
| 2022 | $77.38 M | -71.59% |
| 2021 | $0.27 B | 94.67% |
| 2020 | $0.13 B | -29.99% |
| 2019 | $0.19 B | 38.76% |
| 2018 | $0.14 B | -57.41% |
| 2017 | $0.33 B | 458.95% |
| 2016 | $60.5 M | -33.67% |
| 2015 | $91.21 M | 19.82% |
| 2014 | $76.12 M |
End of Day market cap according to different sources
On May 2nd, 2024 the market cap of Pieris Pharmaceuticals was reported to be:
$13.9 Million
$13.9 Million
$13.9 Million
$1.11 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $80.77 B | 589,417.01% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | 3,249.25% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $9.47 M | -30.86% | 🇺🇸 USA |